Similar response to biologic therapy across racial and ethnic groups among patients with psoriasis enrolled in the CorEvitas Psoriasis Registry

Abstract

To the Editor: Psoriasis impacts 7 million Americans of all ethnoracial backgrounds. Racial/ethnic differences in response to biologic therapy for psoriasis have been described in clinical trials1; yet, these findings do not reflect real-world outcomes.2 Data from clinical practice are needed to further our understanding of potential variability in the effectiveness of biologics. We used data from the CorEvitas Psoriasis Registry,3 an observational cohort of patients evaluated in dermatology clinics, to better understand the response to biologics across racial/ethnic groups.